Results 131 to 140 of about 34,465 (168)
Some of the next articles are maybe not open access.

Pharmacoeconomics of linezolid

Expert Opinion on Pharmacotherapy, 2008
New antibiotics efficacious in infections caused by resistant Gram-positive microorganisms and with acceptable costs for national health systems per unit of effectiveness are needed.This paper aimed to summarize all available evidence regarding the pharmacoeconomics of linezolid.A systematic review of pharmacoeconomic analyses through a non-restricted ...
Santiago, Grau, Carlos, Rubio-Terrés
openaire   +2 more sources

Linezolid

Neonatal Network, 2009
THE MOST RECENT DATA FROM THE National Institute of Child Health and Human Development Neonatal Research Network revealed that in late-onset sepsis events in very low birth weight neonates proven by blood culture, 70 percent were caused by Gram-positive organisms.
openaire   +3 more sources

Linezolid

Reactions Weekly, 2023
openaire   +2 more sources

Linezolid

Drugs of the Future, 1996
J. Lizondo, X. Rabasseda, J. Castañer
openaire   +1 more source

Linezolid

Reactions Weekly, 2021
openaire   +1 more source

Home - About - Disclaimer - Privacy